Peripheral Intervention

  • Zilver<sup>®</sup> PTX<sup>®</sup> data show<br/>continued patency<br/>at five years

    product

    Zilver® PTX® data show
    continued patency
    at five years

    Five-year results from the largest and longest-running clinical trial of a drug-eluting stent for treating peripheral arterial disease (PAD) confirmed long-term patency for patients treated with Zilver PTX.

    Read More
  • A rich history<br/>of partnership<br/>with physicians

    feature

    A rich history
    of partnership
    with physicians

    It's been more than a half-century since Bill Cook began working with Charles Dotter. That collaboration shaped today's Cook Medical when it brings new products to market.

    Read More
  • Cross lesions<br/> with just one set

    technology

    Cross lesions
    with just one set

    TriForce® Peripheral Crossing Set was designed to cross vascular lesions using a tungsten-loaded tip to aid pushability. This animation shows how it works.

    Read More
  • Expand your interventional<br/>skill set in 2015

    feature

    Expand your interventional
    skill set in 2015

    The Vista Collaboration and Learning Program offers introductory, intermediate, and advanced endovascular workshops.

    Read More
Experience the new era in SFA treatment with drug elution
Plus

Experience the new era in SFA treatment with drug elution

Achieve superior outcomes with the only SFA stent that has a proven drug effect.

Learn MoreLearn More
Download the Peripheral Intervention catalog
Plus

Download the Peripheral Intervention catalog

This 2014 catalog includes more than 2,000 stock products that are approved for sale in the U.S.

Learn MoreLearn More

Cook hosts BTK lunch symposium at NCVH

May 26th, 2015
RCN Forum March2

Cook will host a lunch symposium on Thursday, May 28, during the 16th annual New Cardiovascular Horizons (NCVH) conference in New Orleans. The symposium, titled “New Frontiers in Limb Salvage: From Access to Treatment,” will be held at noon in Chamber II and IV, Mayor’s Suite Level. Speakers include: Dr. Robert Beasley, “How I Treat…

Read More »

Join us: The business of PAD, treating the SFA at NCVH

May 26th, 2015
Breedlove_Mark_2014

Cook Medical’s Peripheral Intervention (PI) division takes center stage at the 16th annual New Cardiovascular Horizons (NCVH) conference, May 27-29, in New Orleans. On Tuesday, May 26, Mark Breedlove, PI vice president and global leader, will discuss the business of peripheral arterial disease (PAD) during a talk titled, “Medical Innovation: Can New Technology Reduce Costs?”…

Read More »

Historic tibiopedal study shows access and crossing success

May 12th, 2015
pedal-306x196

A tibiopedal approach showed 93.5% technical access success and 86.0% technical crossing success in a study sponsored by Cook Medical. Tibiopedal Access for Crossing of Infrainguinal Occlusions (TACO) is the world’s first multicenter, prospective, international study looking at success rates for access and crossing from a tibiopedal approach. The objective of this non-randomized, post-market, observational study was…

Read More »

Showing 1 - 4 of 96 results.

Upcoming Events

  • May 27, 2015 - May 29, 2015
    NCVH--New Cardiovascular Horizons
    New Orleans, LA
  • June 17, 2015 - June 20, 2015
    SVS-Society for Vascular Surgery
    Chicago, Illinois

Social Media

linkedin youtube
Give Us Feedback